Clarius Group LLC’s LeonaBio Inc LONA Stock Holding History

Clarius Group LLC’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,355	Closed	-$16.2K	–	406
2025 Q2	$16.2K	Hold	5,355	–	–	﹤0.01%	479
2025 Q1	$15.3K	Hold	5,355	–	–	﹤0.01%	482
2024 Q4	$31.4K	Hold	5,355	–	–	﹤0.01%	451
2024 Q3	$23.9K	Hold	5,355	–	–	﹤0.01%	453
2024 Q2	$142K	Hold	5,355	–	–	0.01%	429
2024 Q1	$147K	Hold	5,355	–	–	0.01%	465
2023 Q4	$130K	Buy	5,355 +1,412	+36%	+$25K	0.01%	466
2023 Q3	$79.6K	Buy	+3,943	New	+$101K	0.01%	450
2023 Q2	–	Sell	-3,800	Closed	-$95K	–	494
2023 Q1	$95K	Buy	3,800 +517	+16%	+$16.6K	0.01%	495
2022 Q4	$104K	Hold	3,283	–	–	0.01%	497
2022 Q3	$97K	Hold	3,283	–	–	0.01%	476
2022 Q2	$100K	Sell	3,283 -24	-0.7%	-$2.2K	0.01%	458
2022 Q1	$431K	Hold	3,307	–	–	0.03%	275
2021 Q4	$431K	Hold	3,307	–	–	0.03%	275
2021 Q3	$310K	Buy	3,307 +24	+0.7%	+$2.44K	0.03%	310
2021 Q2	$336K	Hold	3,283	–	–	0.03%	290
2021 Q1	$604K	Buy	+3,283	New	+$724K	0.06%	159

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Clarius Group LLC's LONA Position: Q3 2025 in Review

Clarius Group LLC sold out of LeonaBio Inc (LONA) in Q3 2025, closing a stake of 5,355 shares — an estimated $16.2K sold.

Clarius Group LLC first reported a position in LONA in Q1 2021 and held it in 17 quarters. The position peaked at $604K in Q1 2021. 34 funds tracked by Wall St. Rank hold LONA as of Q3 2025.

Clarius Group LLC reported no remaining LeonaBio Inc position as of Q3 2025 after selling out during the quarter.
Clarius Group LLC sold 5,355 LeonaBio Inc shares in Q3 2025, an estimated $16.2K.
Clarius Group LLC first reported a position in LeonaBio Inc in Q1 2021 and held it in 17 quarters.
Clarius Group LLC's LeonaBio Inc position peaked at $604K in Q1 2021.
34 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2025.

Based on Clarius Group LLC's 13F filing for Q3 2025, filed 14 Oct 2025.